Cargando…

Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides

BACKGROUND: Single-cell assays of immune function are increasingly used to monitor T cell responses in immunotherapy clinical trials. Standardization and validation of such assays are therefore important to interpretation of the clinical trial data. Here we assess the levels of intra-assay, inter-as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maecker, Holden T, Hassler, Jeffrey, Payne, Janice K, Summers, Amanda, Comatas, Karrie, Ghanayem, Manar, Morse, Michael A, Clay, Timothy M, Lyerly, Herbert K, Bhatia, Sonny, Ghanekar, Smita A, Maino, Vernon C, delaRosa, Corazon, Disis, Mary L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Methodology Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275721/ https://www.ncbi.nlm.nih.gov/pubmed/18366814 http://dx.doi.org/10.1186/1471-2172-9-9

Ejemplares similares

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT
por: Maecker, Holden T, et al.
Publicado: (2005)

Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors
por: Ghanekar, Smita A, et al.
Publicado: (2007)

Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses
por: Goodell, Vivian, et al.
Publicado: (2007)

Performance of plate-based cytokine flow cytometry with automated data analysis
por: Suni, Maria A, et al.
Publicado: (2003)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
por: Nowacki, Tobias M., et al.
Publicado: (2012)

Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients
por: Kwon, Ji-Soo, et al.
Publicado: (2017)

Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors
por: Pita-Lopez, María Luisa, et al.
Publicado: (2009)

Diagnostic performance of cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in kidney transplantation: A PRISMA-compliant article
por: Ruan, Yashi, et al.
Publicado: (2019)

Immune monitoring technology primer: flow and mass cytometry
por: Maecker, Holden T., et al.
Publicado: (2015)

Optimizing the cryopreservation of murine splenocytes for improved antigen-specific T cell function in ELISPOT
por: Gad, Ekram, et al.
Publicado: (2013)

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
por: Janetzki, Sylvia, et al.
Publicado: (2007)

Full spectrum flow cytometry and mass cytometry: A 32‐marker panel comparison
por: Jaimes, Maria C., et al.
Publicado: (2022)

Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients
por: Seo, Euri, et al.
Publicado: (2021)

An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity
por: Barabas, Sascha, et al.
Publicado: (2017)

Correction: Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients
por: Seo, Euri, et al.
Publicado: (2023)

Modified ELISPOT: Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials
por: Malyguine, Anatoli
Publicado: (2005)

Aging and CMV discordance are associated with increased immune diversity between monozygotic twins
por: Yan, Zheng, et al.
Publicado: (2021)

Detection of Low Abundance RNA Molecules in Individual Cells by Flow Cytometry
por: Hanley, Mary Beth, et al.
Publicado: (2013)

Persistent immunity after therapeutic vaccination targeting HER2/neu correlated with post-vaccination magnitude of interferon gamma Elispot responses
por: Liao, John B, et al.
Publicado: (2014)

1575. Clinical Validation of a Novel ELISpot-based in vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in SOT and HSCT Immunocompromised Patients
por: Banas, Bernhard, et al.
Publicado: (2018)

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells
por: McGuire, Helen M, et al.
Publicado: (2020)

Comparative Multi-Donor Study of IFNγ Secretion and Expression by Human PBMCs Using ELISPOT Side-by-Side with ELISA and Flow Cytometry Assays
por: Hagen, Jodi, et al.
Publicado: (2015)

Response definition criteria for ELISPOT assays revisited
por: Moodie, Z., et al.
Publicado: (2010)

Dynamics of the Acetylcholinesterase Tetramer
por: Gorfe, Alemayehu A., et al.
Publicado: (2008)

Standardization of cytokine flow cytometry assays
por: Maecker, Holden T, et al.
Publicado: (2005)

Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection
por: Hill, Philip C, et al.
Publicado: (2007)

ELISPOT Cell Analysis Assay: Searching for Extracellular Footprints
por: Kalyuzhny, Alexander E.
Publicado: (2011)

Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients
por: Xu, Yuanxin, et al.
Publicado: (2008)

VACUTAINER(® )CPT™ and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples
por: Ruitenberg, Joyce J, et al.
Publicado: (2006)

Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients
por: Ishiyama, Kenichi, et al.
Publicado: (2022)

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases
por: Aiken, Alexander M, et al.
Publicado: (2006)

High Reproducibility of ELISPOT Counts from Nine Different Laboratories
por: Sundararaman, Srividya, et al.
Publicado: (2015)

ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis
por: Ettischer‐Schmid, N., et al.
Publicado: (2020)

Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy
por: Nair, Nitya, et al.
Publicado: (2015)

Modulation of Adult Mesenchymal Stem Cells Activity by Toll-Like Receptors: Implications on Therapeutic Potential
por: DelaRosa, Olga, et al.
Publicado: (2010)

Mass Cytometry Defines Virus-Specific CD4(+) T Cells in Influenza Vaccination
por: Subrahmanyam, Priyanka B., et al.
Publicado: (2020)

The formation pathway of i-motif tetramers
por: Leroy, Jean-Louis
Publicado: (2009)

A Heterospecific Leucine Zipper Tetramer
por: Deng, Yiqun, et al.
Publicado: (2008)

Molecular structure of soluble vimentin tetramers
por: Vermeire, Pieter-Jan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sj04geva0bldd4hca8cg8p5e4d